Form 4 for URGN UroGen Pharma Ltd.
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0001209191-22-006383 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-02 | 2022-01-31 | URGN | Barrett Elizabeth A. | CEO | S - Sale+OE | $7.58 | -8,195 | 301.0K | -3% | -$62.1K |
| DM | 2022-02-02 | 2022-01-31 | URGN | Barrett Elizabeth A. | CEO | M - OptEx | — | +18.3K | 314.3K | +6% | — |
| DM | 2022-02-02 | 2022-01-31 | URGN | Barrett Elizabeth A. | CEO | M - OptEx | $0.00 | -18.3K | 5,000 | -79% | $0 |
| D | 2022-02-02 | 2022-01-31 | URGN | Barrett Elizabeth A. | CEO | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-01-31 | S | D | 5,960 | $7.58 | 308,358 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units |
| 2 | Common | Ordinary Shares | 2022-01-31 | M | A | 5,000 | — | 303,220 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer |
| 3 | Common | Ordinary Shares | 2022-01-31 | S | D | 2,235 | $7.58 | 300,985 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units |
| 4 | Common | Ordinary Shares | 2022-01-31 | M | A | 13,333 | — | 314,318 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer |
| 5 | Derivative | Restricted Stock Units | 2022-01-31 | M | D | 13,333 | $0.00 | 26,667 | D | — · — to — | 13,333 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer (F4) The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022. |
| 6 | Derivative | Restricted Stock Units | 2022-01-31 | M | D | 5,000 | $0.00 | 5,000 | D | — · — to — | 5,000 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer (F3) The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021. |
| 7 | Derivative | Stock Option (right to buy) | 2022-01-31 | A | A | 150,000 | $0.00 | 150,000 | D | $7.72 · — to 2032-01-31 | 150,000 Ordinary Shares | (F5) 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025 |